Livongo Committed to Success at La Crosse Ride

On Saturday, Aug. 11th, 160 Team Illinois cyclists will descend on La Crosse, Wisconsin, for the JDRF Ride to Cure Diabetes. Among the riders is a team of more than 102 passionate individuals from Livongo Health who spend their days working to make it easier for people with diabetes to stay healthy until a cure is found.

For Livongo, the cause is personal. Glen Tullman, Livongo’s Chief Executive Officer, has attracted a following of individuals with a connection to diabetes and other conditions. It’s no surprise that Livongo’s ride team tripled in size from last year since one-third of its employees have diabetes and another third have family members struggling with other chronic conditions.

“Livongo is always pushing the envelope, whether it be in revolutionizing chronic-condition management or in bringing together one of the largest teams to participate in JDRF’s Ride to Cure Diabetes,” Tullman said. “We live our mission, and we challenge other organizations in diabetes – many that are much larger than us – to show that it’s more than just a business to them, to give directly, and to get out and ride for a cure side-by-side with us.”

At the conclusion of the 2018 Ride season, Livongo and its riders will have raised more than $280,000 in sponsorship and fundraising dollars. The company also contributes to the JDRF Illinois One Dream Gala and participates in many JDRF One Walk events in Illinois and across the U.S., helping to raise additional funds to prevent and ultimately cure T1D.

“We are grateful for Livongo’s commitment to helping people with type 1 diabetes live healthier lives and its support for the JDRF Ride to Cure Diabetes,” said Derek Rapp, JDRF president and CEO. “Livongo’s spirit of innovation and determination is seemingly always on display, and the company’s leadership and fundraising efforts play an important role in bringing us closer to a cure.”

Click here to learn more about Livongo and its mission to reinvent the experience of having diabetes, making it less difficult to manage, safer, and eliminating the hassles that people with diabetes face on a daily basis.